Monocytosis is a common finding that is caused by a wide variety of neoplastic and non-neoplastic conditions. The adequate evaluation of monocytosis involves the integration of laboratory data, morphology, clinical findings, and the judicious use of ancillary studies. We review the literature on monocytosis, including the 2017 revised 4th edition of the World Health Organization classification of hematopoietic neoplasms.We present a review of monocytosis with practical guidelines on how to approach both routine and challenging cases.
K E Y W O R D Sblood, bone marrow, leukemia, monocytes, morphology, myeloid
| INTRODUCTIONCirculating peripheral blood monocytes are key players in the innate immune system. Although not distinct morphologically, dendritic cells and precursors also circulate. These monocytic/dendritic cells are derived primarily from bone marrow hematopoietic stem cells and are highly versatile with capacity to migrate to sites of inflammation, differentiate into tissue macrophages and specialized dendritic cell subtypes, secrete cytokines and chemokines to attract other inflammatory cells, and phagocytose tissue debris and microorganisms. They also participate in the initiation of adaptive immunity by presenting antigens to antigen-specific lymphocytes. The effector functions and roles played by these cells in mediating acute and chronic inflammation, antimicrobial defense, and tissue repair and wound healing are vital to the maintenance of a healthy steady state. When dysfunctional or dysregulated, however, monocytes can contribute to and cause significant disease. The purpose of this review was present a strategy to investigate monocytosis primarily in the adult patient.
| BACKGROUNDIn the healthy adult and child, monocytes typically comprise between 1 and 9 percent of total peripheral blood leukocytes, with the absolute